BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25393454)

  • 21. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
    J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.
    Wolfson JA; Richman JS; Sun CL; Landier W; Leung K; Smith EP; O'Donnell M; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1133-1141. PubMed ID: 30262597
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98.
    Stark B; Nirel R; Avrahami G; Abramov A; Attias D; Ballin A; Bielorai B; Burstein Y; Gavriel H; Elhasid R; Kapelushnik J; Sthoeger D; Toren A; Wientraub M; Yaniv I; Izraeli S
    Leukemia; 2010 Feb; 24(2):419-24. PubMed ID: 20016534
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.
    Liang DC; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Peng CT; Lin MT; Chang TK; Jaing TH; Liu HC; Wang LY; Yeh TC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Wu KH; Hung GY; Chen RL; Chen SH; Cheng SN; Chang YH; Chen BW; Ho WL; Wang JL; Lin ST; Hsieh YL; Wang SC; Chang HH; Yang YL; Huang FL; Chang CY; Chang WH; Lin KS
    Leukemia; 2010 Feb; 24(2):397-405. PubMed ID: 20016538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays.
    Suarez A; Piña M; Nichols-Vinueza DX; Lopera J; Rengifo L; Mesa M; Cardenas M; Morrissey L; Veintemilla G; Vizcaino M; Del Toro L; Vicuna V; Fernandez J; Neuberg D; Stevenson K; Gutierrez A
    Pediatr Blood Cancer; 2015 Aug; 62(8):1395-402. PubMed ID: 25808195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute Lymphocyte Count Recovery Independently Predicts Outcome in Childhood Acute Lymphoblastic Leukemia: Experience From a Tertiary Care Cancer Center of a Developing Country.
    Gupta A; Kapoor G; Jain S; Bajpai R
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e143-9. PubMed ID: 26201035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of childhood acute lymphoblastic leukemia care in Shanghai, China.
    Liu Y; Chen J; Tang J; Ni S; Xue H; Pan C
    Pediatr Blood Cancer; 2009 Oct; 53(4):557-62. PubMed ID: 19526524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of diagnosis and prognosis of infant acute leukemia in China.
    Huang LB; Guan XQ; Zhang YC; Zhang XL; Ke ZY; Luo XQ
    Pediatr Blood Cancer; 2009 Dec; 53(6):973-7. PubMed ID: 19588516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years.
    Kulkarni KP; Arora RS; Marwaha RK
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):475-9. PubMed ID: 21792045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of children and adolescents with a second or third relapse of acute lymphoblastic leukemia (ALL): a population-based analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) study group.
    Reismüller B; Peters C; Dworzak MN; Pötschger U; Urban C; Meister B; Schmitt K; Dieckmann K; Gadner H; Attarbaschi A; Mann G;
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):e200-4. PubMed ID: 23652878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children.
    Inagaki J; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
    Pediatr Blood Cancer; 2015 Apr; 62(4):674-9. PubMed ID: 25546601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute lymphoblastic leukemias off therapy: course of 80 cases after treatment cessation].
    Sánchez Fayos J; Bernacer M; Olavarría E; Outeiriño J; Prieto E; Román A; Pacho E; Villalobos E; Pérez A; Myric A
    Sangre (Barc); 1992 Dec; 37(6):439-47. PubMed ID: 1293795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.
    Escherich G; Horstmann MA; Zimmermann M; Janka-Schaub GE;
    Leukemia; 2010 Feb; 24(2):298-308. PubMed ID: 20016530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of hepatitis B infection in pediatric acute lymphoblastic leukemia in a tertiary care center from South India.
    Guruprasad B; Kavitha S; Aruna Kumari BS; Vijaykumar BR; Sumati BG; Mahua S; Appaji L; Jayshree RS
    Pediatr Blood Cancer; 2014 Sep; 61(9):1616-9. PubMed ID: 24798418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
    Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
    Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.
    Möricke A; Zimmermann M; Reiter A; Henze G; Schrauder A; Gadner H; Ludwig WD; Ritter J; Harbott J; Mann G; Klingebiel T; Zintl F; Niemeyer C; Kremens B; Niggli F; Niethammer D; Welte K; Stanulla M; Odenwald E; Riehm H; Schrappe M
    Leukemia; 2010 Feb; 24(2):265-84. PubMed ID: 20010625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of relapse in childhood ALL: challenges and lessons from a uniform treatment protocol.
    Arya LS; Kotikanyadanam SP; Bhargava M; Saxena R; Sazawal S; Bakhshi S; Khattar A; Kulkarni KP; Adde M; Vats TS; Magrath I
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):370-5. PubMed ID: 20463606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
    Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
    Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.